Bioreductive drugs and the selective induction of tumour hypoxia.

por Bremner, J. C., Stratford, I. J., Bowler, J., Adams, G. E.
Publicado 1990

Magnetic resonance spectroscopic studies on 'real-time' changes in RIF-1 tumour metabolism and blood flow during and after photodynamic therapy.

por Bremner, J. C., Bradley, J. K., Stratford, I. J., Adams, G. E.
Publicado 1994

(31)P magnetic resonance spectroscopy as a predictor of efficacy in photodynamic therapy using differently charged zinc phthalocyanines

por Bremner, J C M, Wood, S R, Bradley, J K, Griffiths, J, Adams, G E, Brown, S B
Publicado 1999

In vivo 31P nuclear magnetic resonance spectroscopy of experimental murine tumours and human tumour xenografts: effects of blood flow modification.

por Bremner, J. C., Counsell, C. J., Adams, G. E., Stratford, I. J., Wood, P. J., Dunn, J. F., Radda, G. K.
Publicado 1991

Increasing the effect of photodynamic therapy on the RIF-1 murine sarcoma, using the bioreductive drugs RSU1069 and RB6145.

por Bremner, J. C., Adams, G. E., Pearson, J. K., Sansom, J. M., Stratford, I. J., Bedwell, J., Bown, S. G., MacRobert, A. J., Phillips, D.
Publicado 1992